Skip to Content

I4337 2 mg (Terazosin Hydrochloride 2 mg)

Pill with imprint I4337 2 mg is White & Yellow, Capsule-shape and has been identified as Terazosin Hydrochloride 2 mg. It is supplied by Teva Pharmaceuticals USA.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for I4337 2 mg

Terazosin Hydrochloride

Imprint
I4337 2 mg
Strength
2 mg
Color
White & Yellow
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-4337
Inactive Ingredients
corn starch, crospovidone, D&C Yellow No. 10, aluminum oxide, FD&C Blue No. 1, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40, gelatin, lactose monohydrate, magnesium stearate, propylene glycol, shellac, ferrosoferric oxide, magnesium silicate, titanium dioxide, D&C Red No. 33

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.